Skin Cancer Associated Genodermatoses: A Literature Review

Acta Derm Venereol. 2019 Apr 1;99(4):360-369. doi: 10.2340/00015555-3123.

Abstract

Skin cancer has become the most common type of cancer worldwide as a result of environmental exposure and medical treatments. A small group of patients are genetically predisposed to skin cancer and this article is intended as a diagnostic tool when encountering patients with multiple skin cancer lesions. The disorders are described with clinical characteristics, genetics and management. The most common syndromes associated with basal cell carcinoma are: Gorlin-Goltz syndrome, Rombo syndrome, and Bazex-Dupré-Christol syndrome. Multiple squamous cell carcinomas can be related to: xeroderma pigmentosum, Ferguson-Smith, Muir-Torre syndrome, Mibelli-type porokeratosis, keratitis-ichthyosis-deafness syndrome, Rothmund-Thomson syndrome, Bloom syndrome, and epidermodysplasia verruciformis. Malignant melanoma can be inherited, as in familial atypical multiple mole melanoma syndrome.

Keywords: basal cell carcinoma; genodermatoses; hereditary skin cancer; skin cancer; squamous cell carcinoma.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Adult
  • Biomarkers, Tumor / genetics*
  • Carcinoma, Basal Cell / diagnosis
  • Carcinoma, Basal Cell / genetics*
  • Carcinoma, Basal Cell / therapy
  • Carcinoma, Squamous Cell / diagnosis
  • Carcinoma, Squamous Cell / genetics*
  • Carcinoma, Squamous Cell / therapy
  • Child
  • Child, Preschool
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Male
  • Melanoma / diagnosis
  • Melanoma / genetics*
  • Melanoma / therapy
  • Middle Aged
  • Mutation*
  • Neoplastic Syndromes, Hereditary / diagnosis
  • Neoplastic Syndromes, Hereditary / genetics*
  • Neoplastic Syndromes, Hereditary / therapy
  • Phenotype
  • Risk Assessment
  • Risk Factors
  • Skin / pathology
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / genetics*
  • Skin Neoplasms / therapy
  • Treatment Outcome
  • Young Adult

Substances

  • Biomarkers, Tumor